XML 33 R23.htm IDEA: XBRL DOCUMENT
v3.5.0.2

Balance Sheet Components (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Summary of Cash Equivalents and Available-for-sale Securities | Cash equivalents and available-for-sale securities consisted of the following (in thousands):
|  | September 30, 2016 |
|  | Amortized Cost |  |  | Gross Unrealized |  |  |  |
|  |  | Gains |  |  | Losses |  |  | Fair Value |
Money market funds |  | $ | 95,122 |  |  | $ | — |  |  | $ | — |  |  | $ | 95,122 |
Corporate bonds |  |  | 600 |  |  |  | — |  |  |  | — |  |  |  | 600 |
Commercial paper |  |  | 1,899 |  |  |  | — |  |  |  | — |  |  |  | 1,899 |
Total cash equivalents and available-for-sale securities |  | $ | 97,621 |  |  | $ | — |  |  | $ | — |  |  | $ | 97,621 |
Classified as: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash equivalents |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 95,122 |
Available-for-sale securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,499 |
Total cash equivalents and available-for-sale securities |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 97,621 |
|  | December 31, 2015 |
|  | Amortized Cost |  |  | Gross Unrealized |  |  |  |
|  |  | Gains |  |  | Losses |  |  | Fair Value |
Money market funds |  | $ | 2,136 |  |  | $ | — |  |  | $ | — |  |  | $ | 2,136 |
Corporate bonds |  |  | 7,373 |  |  |  | — |  |  |  | (5 | ) |  |  | 7,368 |
Commercial paper |  |  | 500 |  |  |  | — |  |  |  | — |  |  |  | 500 |
Total cash equivalents and available-for-sale securities |  | $ | 10,009 |  |  | $ | — |  |  | $ | (5 | ) |  | $ | 10,004 |
Classified as: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash equivalents |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 2,136 |
Available-for-sale securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 7,868 |
Total cash equivalents and available-for-sale securities |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 10,004 |
Summary of Accrued Expenses and Other Payables | Accrued expenses and other payables consisted of the following (in thousands):
|  | September 30, 2016 |  |  | December 31, 2015 |
Accrued clinical and research related expenses |  | $ | 1,630 |  |  | $ | 976 |
Accrued employee related expenses |  |  | 1,074 |  |  |  | 754 |
Other |  |  | 310 |  |  |  | 149 |
Total accrued expenses and other payables |  | $ | 3,014 |  |  | $ | 1,879 |

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of cash, cash equivalents, and investments. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration